Abstract

The two Ral GTPases, RalA and RalB, have crucial roles downstream Ras oncoproteins in human cancers; in particular, RalB is involved in invasion and metastasis. However, therapies targeting Ral signalling are not available yet. By a novel optogenetic approach, we found that light-controlled activation of Ral at plasma-membrane promotes the recruitment of the Wave Regulatory Complex (WRC) via its effector exocyst, with consequent induction of protrusions and invasion. We show that active Ras signals to RalB via two RalGEFs (Guanine nucleotide Exchange Factors), RGL1 and RGL2, to foster invasiveness; RalB contribution appears to be more important than that of MAPK and PI3K pathways. Moreover, on the clinical side, we uncovered a potential role of RalB in human breast cancers by determining that RalB expression at protein level increases in a manner consistent with progression toward metastasis. This work highlights the Ras-RGL1/2-RalB-exocyst-WRC axis as appealing target for novel anti-cancer strategies.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Giulia Zago

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Irina Veith

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Manish Singh

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Laetitia Fuhrmann

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Simon De Beco

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda Remorino

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Saori Takaoka

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Marjorie Palmeri

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Frédérique Berger

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Nathalie Brandon

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Ahmed El Marjou

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Anne Vincent-Salomon

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Jacques Camonis

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Mathieu Coppey

    Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Maria Carla Parrini

    Institut Curie, Paris, France
    For correspondence
    maria-carla.parrini@curie.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7082-9792

Funding

Fondation ARC pour la Recherche sur le Cancer (PJA 20151203371)

  • Maria Carla Parrini

Institut National de la Santé et de la Recherche Médicale (PC201530)

  • Mathieu Coppey

Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL)

  • Mathieu Coppey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrea Musacchio, Max Planck Institute of Molecular Physiology, Germany

Version history

  1. Received: July 31, 2018
  2. Accepted: October 14, 2018
  3. Accepted Manuscript published: October 15, 2018 (version 1)
  4. Version of Record published: November 9, 2018 (version 2)
  5. Version of Record updated: November 13, 2018 (version 3)

Copyright

© 2018, Zago et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,019
    views
  • 273
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Giulia Zago
  2. Irina Veith
  3. Manish Singh
  4. Laetitia Fuhrmann
  5. Simon De Beco
  6. Amanda Remorino
  7. Saori Takaoka
  8. Marjorie Palmeri
  9. Frédérique Berger
  10. Nathalie Brandon
  11. Ahmed El Marjou
  12. Anne Vincent-Salomon
  13. Jacques Camonis
  14. Mathieu Coppey
  15. Maria Carla Parrini
(2018)
RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
eLife 7:e40474.
https://doi.org/10.7554/eLife.40474

Share this article

https://doi.org/10.7554/eLife.40474

Further reading

    1. Cell Biology
    Zhongyun Xie, Yongping Chai ... Wei Li
    Research Article

    Asymmetric cell divisions (ACDs) generate two daughter cells with identical genetic information but distinct cell fates through epigenetic mechanisms. However, the process of partitioning different epigenetic information into daughter cells remains unclear. Here, we demonstrate that the nucleosome remodeling and deacetylase (NuRD) complex is asymmetrically segregated into the surviving daughter cell rather than the apoptotic one during ACDs in Caenorhabditis elegans. The absence of NuRD triggers apoptosis via the EGL-1-CED-9-CED-4-CED-3 pathway, while an ectopic gain of NuRD enables apoptotic daughter cells to survive. We identify the vacuolar H+–adenosine triphosphatase (V-ATPase) complex as a crucial regulator of NuRD’s asymmetric segregation. V-ATPase interacts with NuRD and is asymmetrically segregated into the surviving daughter cell. Inhibition of V-ATPase disrupts cytosolic pH asymmetry and NuRD asymmetry. We suggest that asymmetric segregation of V-ATPase may cause distinct acidification levels in the two daughter cells, enabling asymmetric epigenetic inheritance that specifies their respective life-versus-death fates.

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.